Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03385486
Brief Title: Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors

First Submitted : December 3, 2017
First Submitted that Met QC Criteria : December 20, 2017
First Posted : December 28, 2017

Last Update Submitted that Met QC Criteria : December 31, 2020
Last Update Posted : January 5, 2021